Table 1.
Outcome | Median (range) ICC | Trials |
---|---|---|
Composite adverse neonatal outcome 1* | 0.68 (0.52–0.71) | 5–9,15,17,18,21 |
Composite adverse neonatal outcome 2** | 0.65 (0.54–0.77) | 4–9,15,17,18,20,21 |
Perinatal death | 0.66 (0.17–0.80) | 4,5,7,15,17,18,21 |
Respiratory distress syndrome | 0.65 (0.50–0.74) | 4–9,15,17,18,20,21 |
Bronchopulmonary dysplasia | 0.51 (0.37–0.72) | 5,17,18 |
Intraventricular haemorrhage | 0.36 (0.13–0.45) | 4,5,17 |
Necrotising enterocolitis | 0.13 (0.12–0.14) | 15,18 |
Sepsis | 0.38 (0.35–0.47) | 4,5,7,15,17,18 |
Admission to neonatal intensive care unit | 0.79 (0.56–0.86) | 4–9,15,17,18,21 |
Birthweight | 0.79 (0.62–0.85) | 4–9,15,17–21 |
Birthweight <2500 g | 0.50 (0.37–0.71) | 4–9,15,17–21 |
Birthweight <1500 g | 0.71 (0.36–0.91) | 4–9,15,17,18,20,21 |
Includes perinatal death, respiratory distress syndrome, bronchopulmonary dysplasia, intraventricular haemorrhage, necrotising enterocolitis, and sepsis.
Includes perinatal death, respiratory distress syndrome, intraventricular haemorrhage, and necrotising enterocolitis.